about
Cancer immunotherapy products: regulatory aspects in the European Union.Development and regulation of biosimilars: current status and future challenges.Meeting Report: PDA Virus and TSE Safety Forum.Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use.Meeting report--workshop on virus removal by filtration: trends and new developments.Challenges with advanced therapy medicinal products and how to meet them.[Regulation and evaluation of clinical trials of cell therapy]In support of the European Union biosimilar frameworkDemonstration of biosimilarity, extrapolation of indications and other challenges related to biosimilars in Europe
P50
Q36631345-C5B9B936-719D-431C-9D8A-E7B7EBE60218Q38095808-93F047FF-1C7A-467A-8DF9-2C0D47EE2FD2Q38097407-EE1F2B85-D777-4467-9F58-4168DB843E4AQ38308667-AC5EDBFC-2D91-47F5-B3C8-B95DBCB41279Q45079861-A5BF5730-218F-4CA5-B127-E6DE43412D12Q45857265-B7E23D95-7C6A-4CF7-B2E5-9B4D1F294523Q84104920-B6EE2040-2C8F-4ACF-ABB2-F3E786D38EC9Q84748552-921E3AAE-B6F8-4EB7-A826-10ADCD9D9A58Q85950928-55BCCCC6-9122-45B8-B61A-D34AC0A9DC91
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sol Ruiz
@en
Sol Ruiz
@nl
type
label
Sol Ruiz
@en
Sol Ruiz
@nl
prefLabel
Sol Ruiz
@en
Sol Ruiz
@nl
P31
P496
0000-0002-2937-0916